SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

PSTI RSS Feed
Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017
Search This Board:
Last Post: 12/8/2016 3:55:02 PM - Followers: 114 - Board type: Free - Posts Today: 0

 

Pluristem Therapeutics Inc. (Nasdaq: PSTI) 

 

 

http://www.pluristem.com/

 

 


 

Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com

 

CIK:  0001158780

 

Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 

 

Management: 

http://www.pluristem.com/index.php/about2/management.html
 

Clinical Program: 

http://www.pluristem.com/index.php/clinic-program.html


Recent News and Press:

http://www.pluristem.com/index.php/press-room.html

http://finance.yahoo.com/q/h?s=PSTI+Headlines

http://seekingalpha.com/symbol/PSTI

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001158780&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


 

 

 

Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501

 

Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
karinek@pluristem.com


 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PSTI News: Pluristem’s PLX-R18 Advances into Second Cohort of Dose Selection Study for Treatment of Acute Radiation Syndrome 12/06/2016 07:00:00 AM
PSTI News: Pluristem Reports First Quarter Fiscal 2017 Corporate and Financial Highlights 11/15/2016 07:00:00 AM
PSTI News: Current Report Filing (8-k) 11/10/2016 01:36:41 PM
PSTI News: Pluristem’s $30 Million Equity Funding Approved by Innovative Medical Management Co.’s Shareholders 11/10/2016 07:00:00 AM
PSTI News: Quarterly Report (10-q) 11/07/2016 04:21:41 PM
PostSubject
#4098   Things are Heating up... It feels different here- Melon4head 12/08/16 03:55:01 PM
#4097   Pluristem’s PLX-R18 Advances into Second Cohort of Dose midastouch017 12/06/16 07:43:11 AM
#4096   Pluristem Reports First Quarter Fiscal 2017 Corporate and midastouch017 11/15/16 08:41:12 AM
#4095   Pluristem’s $30 Million Equity Funding Approved by Innovative midastouch017 11/10/16 08:25:21 AM
#4094   Pluristem Continues to Strengthen its Position in China midastouch017 11/07/16 08:55:58 AM
#4093   Why Pluristem Therapeutics Inc. Is So Undervalued – midastouch017 11/03/16 02:51:17 PM
#4092   Why Pluristem Therapeutics Is So Undervalued – The trendmkr 11/03/16 02:37:23 PM
#4091   Same in Japan...witness Astellas TO OCATA earlier this north40000 10/28/16 02:27:54 PM
#4090   google this regenerative medicine boom time, its about thesaud 10/28/16 09:13:14 AM
#4089   Pluristem Signs Term Sheet for $30 Million Equity midastouch017 10/25/16 08:12:02 AM
#4088   Pluristem CEO Zami Aberman Re-Elected to Alliance for midastouch017 10/13/16 08:14:45 AM
#4087   when are we going to break out of thesaud 09/26/16 09:22:01 AM
#4086   Pluristem Therapeutics, Inc. - "Biotech Nation" midastouch017 09/22/16 09:48:57 AM
#4085   Pluristem Therapeutics Gears Up For Critical Blood Stem trendmkr 09/19/16 01:15:17 PM
#4084   Pluristem Therapeutics Inc. (PSTI) Gears Up For Critical midastouch017 09/19/16 12:47:16 PM
#4083   its only a phase 1 trial but just thesaud 09/14/16 06:31:48 PM
#4082   Pluristem Advances Towards U.S. Clinical Trial in PLX-R18 midastouch017 09/14/16 08:01:45 AM
#4081   I think it's only a matter of time herbster 09/12/16 12:39:06 PM
#4080   Pluristem Provides Fiscal Year 2016 Corporate and Financial Highlights midastouch017 09/12/16 08:17:09 AM
#4079   “This is an opportunity time for Pluristem to midastouch017 09/08/16 08:19:12 AM
#4078   Pluristem to Conduct Symposium on PLX-PAD Potential for midastouch017 09/08/16 08:18:18 AM
#4077   news out psti to hold symposiam in Germany thesaud 09/08/16 08:03:50 AM
#4076   FWIW: Pluristem Therapeutics Inc (NASDAQ:PSTI) Upside Stock Technicals at midastouch017 09/07/16 09:37:49 AM
#4075   either news is coming soon or its just thesaud 09/06/16 11:31:26 AM
#4074   ... coupled with extraordinary midastouch017 09/06/16 11:19:15 AM
#4073   anyone know why we are flying today? thesaud 09/06/16 10:49:06 AM
#4072   Lets hope we hear something soon. I would herbster 08/30/16 08:33:54 AM
#4071   we should be hearing from the niaid soon, thesaud 08/24/16 09:09:34 PM
#4070   Thanks carolinacoast 08/24/16 11:01:33 AM
#4069   I don't know about $3 but this will herbster 08/24/16 10:33:33 AM
#4068   Any confirmation that this is third leg of carolinacoast 08/23/16 03:58:47 AM
#4064   I think it's just a matter of time herbster 08/17/16 02:58:47 PM
#4062   well that would do it, they bought the thesaud 08/16/16 03:37:44 PM
#4061   Most likely because STEM was bought out/merging with scubastevo80 08/16/16 02:52:30 PM
#4060   why are we up 7 per cent today, thesaud 08/16/16 01:29:04 PM
#4059   Nice prediction herbster! midastouch017 08/16/16 01:20:06 PM
#4058   Nice close today. Great entry level at these herbster 08/15/16 06:28:11 PM
#4057   strong day today. Like the green. Just a herbster 08/12/16 11:05:05 AM
#4056   Will Pluristem Therapeutics Succeed in CLI Where Sanofi nyctraydr 08/11/16 04:39:17 PM
#4055   Yes- this is sooooo true. Years ago they Melon4head 08/11/16 12:56:40 PM
#4054   The price is ridiculous it is so undervalued herbster 08/11/16 12:03:42 PM
#4053   PSTI vs. Sanofi for CLI- Great Article here. Melon4head 08/11/16 10:49:05 AM
#4052   $1.50 and there it will stay. This price Melon4head 08/10/16 11:44:16 AM
#4051   the EMA REALLY LIKES PSTI, great news today thesaud 08/09/16 12:40:26 PM
#4050   Interesting that they are using the 300 mg. Melon4head 08/09/16 10:27:55 AM
#4049   Great news for $PSTI. Grant is not a KanoD014 08/09/16 09:43:46 AM
#4048   Pluristem’s Phase III Critical Limb Ischemia Study Wins midastouch017 08/09/16 07:52:06 AM
#4047   News Out. bullrider2 08/09/16 07:36:22 AM
#4046   Looks like the support is at 1.49 and herbster 08/03/16 11:51:02 AM
#4045   I bought several weeks back at 1.23 - emit 08/02/16 06:37:38 PM
PostSubject